Check server response of

Server response
NS records
Whois domain
Response headers
Request headers
Raw HTML code
200 OK - cemdc.com
HTTP Status: 200
User-Agent: Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; [email protected])
Date: Wed, 30 Apr 2025 08:48:58 GMT
Content-Type: text/html;charset=UTF-8
Transfer-Encoding: chunked
Connection: keep-alive
Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=QdJulS%2BqQcX0oiED6wNrIqc%2BnaaaunMZEZS%2BHsBuF%2FYVv6kmh1V99h3KQe0l5DRBYByC05xj3ufuJqij%2BMp0hwt1OCX9s7%2BIzSicKbyoCIj51wXNesHJG%2ByZfVo0RTJSzo8e8AAz9YA%3D"}],"group":"cf-nel","max_age":604800}
NEL: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
Server: cloudflare
CF-RAY: 9385c87d7ebb92d3-CPH
alt-svc: h3=":443"; ma=86400
server-timing: cfL4;desc="?proto=TCP&rtt=15355&min_rtt=15355&rtt_var=7677&sent=1&recv=3&lost=0&retrans=0&sent_bytes=0&recv_bytes=165&delivery_rate=0&cwnd=249&unsent_bytes=0&cid=0000000000000000&ts=0&x=0"

HTTP Code 200 OK

200 status code is a standard successful HTTP server response. It means that the client’s request (e.g., from a browser) was successfully processed, and the server is delivering the requested data.

When is Code 200 used?

  • When loading a web page
  • When successfully receiving an API response
  • When processing a form or another HTTP request

What does Code 200 mean for the user?

The user receives content without errors, and the page or application functions properly. If Code 200 is accompanied by data, the browser or program processes and displays it to the user.

GET / HTTP/1.1
Host: cemdc.com
Accept: */*
User-Agent: Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; [email protected])
<!DOCTYPE html><html lang="en-US"><head><title>Under construction</title><base href="http://www.pharmahungary.com/"><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta http-equiv="X-UA-Compatible" content="IE=Edge"><meta name="robots" content="noindex,nofollow"><meta name="viewport" content="width=device-width,initial-scale=1"><style>*{box-sizing:border-box;margin:0;padding:0}html{line-height:1.15;-webkit-text-size-adjust:100%;color:#313131;font-family:system-ui,-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Helvetica Neue,Arial,Noto Sans,sans-serif,Apple Color Emoji,Segoe UI Emoji,Segoe UI Symbol,Noto Color Emoji}body{display:flex;flex-direction:column;height:100vh;min-height:100vh}.main-content{margin:8rem auto;max-width:60rem;padding-left:1.5rem}@media (width <= 720px){.main-content{margin-top:4rem}}.h2{font-size:1.5rem;font-weight:500;line-height:2.25rem}@media (width <= 720px){.h2{font-size:1.25rem;line-height:1.5rem}}#challenge-error-text{background-image:url(data:image/svg+xml;base64,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);background-repeat:no-repeat;background-size:contain;padding-left:34px}@media (prefers-color-scheme:dark){body{background-color:#222;color:#d9d9d9}}</style><meta http-equiv="refresh" content="360"></head><body><div class="main-wrapper" role="main"><div class="main-content"><noscript><div class="h2"><span id="challenge-error-text">Enable JavaScript and cookies to continue</span></div></noscript></div></div><script>(function(){window._cf_chl_opt={cvId: '3',cZone: "www.pharmahungary.com",cType: 'managed',cRay: '9385c87e21cd92d3',cH: 'KkmTHqY2X4UeQlZP_d33XK1MV6heVpHWiNaagV6Rk3o-1746002938-1.2.1.1-MiSJCi0YxszZfd.cTcokS49PdzOaO7DnOaR4moSHUfk2mT0Qd.KbgnKS9d2U1COF',cUPMDTk: "\/404?__cf_chl_tk=ir_Q6YyEE9AY4wTK53zqub9.gzHSvrh3GEaKR64H4_k-1746002938-1.0.1.1-9iJCGbZsPvjn4YPpyiJUk4k0Ydy_3BGhcBE.Cp03BDQ",cFPWv: 'b',cITimeS: '1746002938',cTplC: 0,cTplV: 5,cTplB: 'cf',cK: "unsupported_browser_beacon",fa: "\/404?__cf_chl_f_tk=ir_Q6YyEE9AY4wTK53zqub9.gzHSvrh3GEaKR64H4_k-1746002938-1.0.1.1-9iJCGbZsPvjn4YPpyiJUk4k0Ydy_3BGhcBE.Cp03BDQ",md: "70diVRYlEHkg7h7dmkIh8hz610crA6YvVyJbrqhfeco-1746002938-1.2.1.1-Db1Q2TyV9.Jy.7ln1JwwGFRxl0uHqC4XiDtGqiCYKELIabe3g3zLczakjhDZXw59eu90IbcPN.7dKJZtJ2unPyq47NOHhIzvvb_RjAD9IDFrGm78l_LD23FIuBJSbYcCXfPcJTbWZEO6xD1CX_ds5wSS5g_TOXk3tBKdcma62PKvhd.c1AQP.jMjz__PjYk.6ykxdbRLt0RbR0b92fG9CpRqPoBuQfe1QYm8hzpeWO7cK5oLsVpXuTMvKoWsMpgaZmDyHsf0h4.UFoGECmMvtZ9.gedpls5pqX4JmubPRJWoPbapZ1ZuajM5J6DnDTjvXTEw8FG75YXcbYUwu.FBnOMjGJ7XFAskaN6o0zxMaGVTsxBv7bcdNVTVaSAMyp7PJgTamqAM1omd2.AdIp4SE7vi8pr8zngkjpbybdo9HPZ88TB21ED3CVGbTU4rsCA9SMAPBct_m2EdOkHfbvc50DFbOxGX.lkOIVoGnMEGxAXKvy4p1O9mFrIIYrYa1qIrfoY_acA_pcO9FKUjnqwPAwjk2qLlyqB9tELW5hHHCoMqoUmY85v2UJeV1PI6j2r2w_NpUNtU6zMAtreAJRpeTPEv0Khw3_EFxzHoQdOKIDemAOyBUG9R_yGcVhCztk0LepPdV3kxZGY2qK7WajmPQblRvr_2ghpTg1dWpPoX7X0.pntK1rCOiPX47pM9Zv4g7mNE47ZMuRvu7JkCbhvcr_cpQzmHmtMQKEBli4TlM0ZyMpPDo9Mk3M8saUsbde.enA.S7Vm5o8XfgDwufLU1_yNQLd_wI1E8v1hKvbQNzWJ7Q1r0dq8ik5WdYdgV9w.vQipB2yhOSISfg_cgC4d0dlSPJ0TV2YBjiaKspeows3TQduuUeHgsur0H5PmTzGXo",mdrd: "zA2Nqj5P0JJi_Ql.wAHxTW9kfX6NUNJ96iluP_Nem8I-1746002938-1.2.1.1-fHkUxZdw8LalDox0yQabo01ory2dLPuzv7yAktmbuwmzLr0XJWwa6wZL5wH_0eUGeRMmqeDhjsVg31wI6ucCyISg.dcLys9YdeZeeNqrpe5BgYMLzT.6I43.wuc6D8CoxfqE8id4UHTUvhFgPPJpTPmttzCP9EgKXx.jwF67tvBq6q1.CwFsNrW6HtVd6qtwVlPXOPg60TOHrNajRM3kumA8eckKRMRoc0s7ux5BK9DLMnUPLu9PZUbBFo30Tt1q131YKGnizHuWy.R6cA0sgBI6zqQ9k4XVuOZw_emmos2lCKsnuyr5t62130i7HDJiHXdSiSvp8puG9tPQqPK2pUdVL.64d.w_tbvaUjuGxFCE0aKXlV8YnUJlNjJqRlmhqzA0yeex.cPtsILyHRecRS4LKsYAqfSKdjv.hXZVAk3dgjXxogTdykqnGYB9m.EjBLb3NhHnm0abC556dM9iffaGUSeAMUx5C8wxdni.bkr3tsMQT_3n8xJz0sl_FXAXRiEcsiUVMvXgILfDuWyTArdi6FCOoQ75petErAgWLi0qnK.rfgS6GB4pBRlKRdXLzXY5UwykyFOm9VfHVlMo34Hm1Y6E.SN8xUznZqUWSIcmIRJM0bdlf7MsJDd2M2111_OXzJ55yuV.rw6asXnFr4XpBN9UGFPlTqV8I4dTGF.c1guvJ6Lvsc_k.h.79ukIU3Lm4gv7hSHMtmioYTqf8ejOzSX1eZFybNz7.Kx5Jfq6f7tqNFAHMQ86b5hMh2E6bcxv0xTRIDNNudTexi5mkzyRIV4kZB3i5pWtw_PEe.2KJu4x6jrEj3r0cqVTxr3H0rLWMYBa4ZJmvwoamFsySXqKvHxPoKlmVU74gFgDqM5PNN6W6saCQQ0V0Y3xsoudjjBG6k3x_1y8TpcxJjZ2oBmKKh2Io0na.wYqm1.CLU6tyVP2PAZAEMM2bBtDOqw_H0p5KLuzZNGaUFPGiQ.WrslgcUscpH3h0PWf_BKE9WoZFe1ROwOepCrp1EYUrcfSoCPFvT1.PwQyImxYwS9pfDQkX.nDRpLQC0pW4y6GTUhrMliqHEhCtz2zTiSDVA41gdva2dCeyfQ3K9mBjCE2itmgcHiAjo_HFr3L8zlY0wC94clPowP6QSk.CJm5Zn3USNb8udVldNlwmT_QFRQvIhBD778ZoL4zGq3NYDo2M3eJ2jzMZW1_o7_z_aZxbTWJtkVgleWVCUPfaYXYvOboEpm0rjfG3AY5g9.x8wTCvEijA3D.V154I6BOqPXP5CbzL_uHtzmj8VSu1v3MS8j3oMCQPkiyEFD.cUvxnjpZxcI2vh8pavUi0qrfAZ2TDGbgRcuBrQhYXX20uH71qW_r9vy_ML5Yl.hOZ80SvVwh8mStcUWiAP9ShmUStEDNfJy9JRAYS5PmjrkIZYcPtTd00mLOlpJy3EpmezH0MA7lplAe0GYDqhTg5e1dBjiGFbQnLTuXz1o_Z95wzFLsC5b7_.OP5Hnr.f5G4ZsO22HnBXQ988mhFNyVddKCIj6nPB_L4VZvHFyH8zD01JjX6YXpUwJYorSFVoz6QXvipIUMWzoHKQOdmB_XrSqo5e8yygP.KFJr9TvaP_.ZGTkrPNOdbGL4Qv5G6m0YOmsy4cUg51lWmtP479FOdMB76NQAYiQKwhMVRbd9nWIDbcyE5egRqrjIbcFY6ZVj5S8nUrPEZaxCnBzoF4jciKmNYq7fibhsYtguCEXbXzsLwiEMPjKCxgRyO8mZ7t2LDW0SY49w5ti6A5a_QdHZwkoPvrPrVqxOu9KYz3QUIRTc_deSnjpjBeQIpxuh.YQwunJiDtOJp9M"};var cpo = document.createElement('script');cpo.src = '/cdn-cgi/challenge-platform/h/b/orchestrate/chl_page/v1?ray=9385c87e21cd92d3';window._cf_chl_opt.cOgUHash = location.hash === '' && location.href.indexOf('#') !== -1 ? '#' : location.hash;window._cf_chl_opt.cOgUQuery = location.search === '' && location.href.slice(0, location.href.length - window._cf_chl_opt.cOgUHash.length).indexOf('?') !== -1 ? '?' : location.search;if (window.history && window.history.replaceState) {var ogU = location.pathname + window._cf_chl_opt.cOgUQuery + window._cf_chl_opt.cOgUHash;history.replaceState(null, null, "\/404?__cf_chl_rt_tk=ir_Q6YyEE9AY4wTK53zqub9.gzHSvrh3GEaKR64H4_k-1746002938-1.0.1.1-9iJCGbZsPvjn4YPpyiJUk4k0Ydy_3BGhcBE.Cp03BDQ" + window._cf_chl_opt.cOgUHash);cpo.onload = function() {history.replaceState(null, null, ogU);}}document.getElementsByTagName('head')[0].appendChild(cpo);}());</script><script>jQuery('.top-cover').remove();jQuery('#contactForm').parent().remove();jQuery('#menu-item-200 a').click(function(e){e.preventDefault();window.location.href='http://pharmahungary.com/';return true;});</script></html>                               

Whois info of domain

Domain Name: CEMDC.COM
Registry Domain ID: 2332864658_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.directnic.com
Registrar URL: http://www.directnic.com
Updated Date: 2024-05-10T14:29:12Z
Creation Date: 2018-11-15T09:18:48Z
Registry Expiry Date: 2025-11-15T09:18:48Z
Registrar: DNC Holdings, Inc.
Registrar IANA ID: 291
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +1.5043550081
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: ALBERT.NS.CLOUDFLARE.COM
Name Server: AMANDA.NS.CLOUDFLARE.COM
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2025-04-30T08:48:46Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
TERMS OF USE: You are not authorized to access or query our Whois
by the following terms of use: You agree that you may use this Data only
to: (1) allow, enable, or otherwise support the transmission of mass